Skip to content

Clinical trials

Phase 3 Metabolic Diseases trials in Spain

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Metabolic Diseases Phase: Phase 3 Country / region: Spain Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20091
20101
20161
20181
20201
20225
20231
20244
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Active, not recruiting5
Recruiting3
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
89bio, Inc.3
Agios Pharmaceuticals, Inc.2
Eli Lilly and Company2
Pfizer2
AstraZeneca1
Bayer1
Diamyd Medical AB1
Ionis Pharmaceuticals, Inc.1
NewAmsterdam Pharma1
Otsuka Pharmaceutical Development & Commercialization, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Metabolic Diseases18
Diabetes Mellitus7
Glucose Metabolism Disorders7
Diabetes Mellitus, Type 26
Endocrine System Diseases5
Digestive System Diseases3
Liver Diseases3
Anemia2
Body Weight2
Dyslipidemias2

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.